Takeda Pharmaceutical (TAK) Other financing activities (2018 - 2020)
Takeda Pharmaceutical (TAK) posted quarterly Other financing activities of -$20.1 million for Q1 2020, down 110.13% year-over-year from $198.9 million in Q2 2019, and down 30.28% quarter-over-quarter from -$15.5 million in Q2 2019.
Takeda Pharmaceutical (TAK) Other financing activities (2018 - 2020) Analysis & Trends
Takeda Pharmaceutical's Other financing activities history runs 3 years deep, the most recent figure standing at -$20.1 million for Q1 2020.
- In Q1 2020, Other financing activities fell 110.13% year-over-year to -$20.1 million; the TTM figure through Mar 2020 stood at $163.3 million (down 7.72% YoY), while the FY2026 annual figure was -$86.4 million, up 20.91% from the prior year.
- Other financing activities for Q1 2020 stood at -$20.1 million, down from -$15.5 million in the prior quarter.
- The five-year high for Other financing activities was $198.9 million in Q1 2019, with the low at -$21.9 million in Q2 2018.
- The 3-year median for Other financing activities is -$17.8 million (2020), against an average of $35.3 million.
- The sharpest annual moves came in 2019 and 2020: Other financing activities advanced 29.53% in 2019, then sank 110.13% in 2020.
- Takeda Pharmaceutical's Other financing activities stood at -$21.9 million in 2018, then rose by 29.53% to -$15.5 million in 2019, then plunged by 30.28% to -$20.1 million in 2020.
- Business Quant data shows TAK's Other financing activities at -$20.1 million in Q1 2020, -$15.5 million in Q2 2019, and $198.9 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -20.14 Mn |
| Mar 31, 2020 | -20.14 Mn |
| Jun 30, 2019 | -15.46 Mn |
| Jun 30, 2019 | -15.46 Mn |
| Mar 31, 2019 | 198.92 Mn |
| Mar 31, 2019 | 198.92 Mn |
| Jun 30, 2018 | -21.94 Mn |
| Jun 30, 2018 | -21.94 Mn |